Analysis of HIV-1 clinical trials: statistical magic? The AVANTI Steering Committee
- PMID: 10376634
Analysis of HIV-1 clinical trials: statistical magic? The AVANTI Steering Committee
Comment in
-
Estimation of missing values.Lancet. 1999 Aug 21;354(9179):686. doi: 10.1016/s0140-6736(05)77672-8. Lancet. 1999. PMID: 10466705 No abstract available.
Similar articles
-
Surrogacy in HIV-1 clinical trials.Lancet. 1998 Feb 21;351(9102):536-7. doi: 10.1016/S0140-6736(98)22008-3. Lancet. 1998. PMID: 9492766 No abstract available.
-
[HIV infections: further options for combination therapy].Dtsch Med Wochenschr. 2003 Jul 11;128(28-29):1523. Dtsch Med Wochenschr. 2003. PMID: 12899165 German. No abstract available.
-
Current strategies in the treatment of HIV infection.Adv Intern Med. 2001;46:207-46. Adv Intern Med. 2001. PMID: 11147254 Review. No abstract available.
-
[Treatment of HIV infections with antiretroviral drugs and recombinant interleukin-2].Ugeskr Laeger. 2000 Oct 16;162(42):5614-8. Ugeskr Laeger. 2000. PMID: 11059298 Review. Danish.
-
[Effectiveness also in general practice conditions. Just as good in routine practice as in studies].MMW Fortschr Med. 2000;142(3 Suppl):36-7. MMW Fortschr Med. 2000. PMID: 10893965 German. No abstract available.
Cited by
-
The role of therapeutic drug monitoring in treatment of HIV infection.Br J Clin Pharmacol. 2001 Apr;51(4):301-8. doi: 10.1046/j.1365-2125.2001.01380.x. Br J Clin Pharmacol. 2001. PMID: 11318764 Free PMC article. Review. No abstract available.
-
Extended-release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living with HIV and Alcohol use Disorders Transitioning to the Community: Results From a Double-Blind, Placebo-Controlled Trial.J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):92-100. doi: 10.1097/QAI.0000000000001759. J Acquir Immune Defic Syndr. 2018. PMID: 29781884 Free PMC article. Clinical Trial.
-
Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.J Acquir Immune Defic Syndr. 2018 May 1;78(1):43-53. doi: 10.1097/QAI.0000000000001634. J Acquir Immune Defic Syndr. 2018. PMID: 29373393 Free PMC article. Clinical Trial.
-
Amprenavir: a review of its clinical potential in patients with HIV infection.Drugs. 2000 Dec;60(6):1383-410. doi: 10.2165/00003495-200060060-00012. Drugs. 2000. PMID: 11152018 Review.
-
Cost-effectiveness of HIV screening in patients older than 55 years of age.Ann Intern Med. 2008 Jun 17;148(12):889-903. doi: 10.7326/0003-4819-148-12-200806170-00002. Ann Intern Med. 2008. PMID: 18559840 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical